43 filings
6-K
CNTB
Connect Biopharma Holdings Ltd
16 Apr 24
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
4:20pm
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Feb 24
Current report (foreign)
4:50pm
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Dec 23
Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma
6:10am
6-K
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
6-K
CNTB
Connect Biopharma Holdings Ltd
1 Nov 23
Current report (foreign)
3:57pm
6-K
btssqpygv10
20 Oct 23
Current report (foreign)
4:44pm
6-K
48fxjbgb jjlsv2o
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
6-K
15dfj05825 0fcn5
12 Sep 23
Current report (foreign)
6:13am
6-K
4nkkrg17f4eofgdz200l
14 Jul 23
Current report (foreign)
5:00pm
6-K
4zqejyr zofa
23 Jun 23
House Lease Contract
4:31pm
6-K
qou819ah
5 Jun 23
Current report (foreign)
4:28pm
6-K
vyp25
1 Jun 23
Current report (foreign)
4:24pm
6-K
dnkphxeko4qo t7e
11 Apr 23
Connect Biopharma Reports Full Year 2022 Financial Results
5:00pm
6-K
08b51wbw
21 Mar 23
Connect Biopharma CBP-201 Atopic Dermatitis Global Phase 2b Data Showed Rapid and Sustained Improvement Across all Body Regions
4:51pm
6-K
qdjilfhsuacb3
8 Feb 23
Connect Biopharma Reports CBP-201 Global Phase 2 Asthma Trial Achieves Full Enrollment
8:35pm
6-K
m3f1sclm
2 Feb 23
Current report (foreign)
7:01pm
6-K
2dmggn
30 Dec 22
Connect Biopharma Provides Business and Clinical Development Program Update
8:00am
6-K
dab2jhx9
2 Dec 22
Current report (foreign)
5:15pm
6-K
fbdtna
4 Oct 22
Current report (foreign)
7:16am
6-K
4fkvu
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm